Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Amortization of Deferred Charges: 2011-2014

Historic Amortization of Deferred Charges for Enanta Pharmaceuticals (ENTA) over the last 3 years, with Sep 2014 value amounting to $8,000.

  • Enanta Pharmaceuticals' Amortization of Deferred Charges fell 60.00% to $2,000 in Q2 2015 from the same period last year, while for Mar 2015 it was $3,000, marking a year-over-year decrease of 87.50%. This contributed to the annual value of $8,000 for FY2014, which is 74.19% down from last year.
  • As of FY2014, Enanta Pharmaceuticals' Amortization of Deferred Charges stood at $8,000, which was down 74.19% from $31,000 recorded in FY2013.
  • Enanta Pharmaceuticals' Amortization of Deferred Charges' 5-year high stood at $2.1 million during FY2011, with a 5-year trough of $8,000 in FY2014.
  • Its 2-year average for Amortization of Deferred Charges is $19,500, with a median of $19,500 in 2013.
  • Data for Enanta Pharmaceuticals' Amortization of Deferred Charges shows a maximum YoY crashed of 74.19% (in 2014) over the last 5 years.
  • Over the past 3 years, Enanta Pharmaceuticals' Amortization of Deferred Charges (Yearly) stood at $2.1 million in 2011, then reached $31,000 in 2013, then plummeted by 74.19% to $8,000 in 2014.